European Journal of Dermatology
MENULocalized skin necrosis by bevacizumab Volume 23, numéro 2, March-April 2013
Illustrations
Hospital General Universitario de Alicante,
C/Pintor Baeza s/n,
03010 Alicante, Spain
- DOI : 10.1684/ejd.2013.1952
- Page(s) : 251-2
- Année de parution : 2013
ejd.2013.1952 Auteur(s) : Laura Frances laura.frances@hotmail.com, Jaime Guijarro, Maria del Carmen Leiva-Salinas, Maria Pilar Albares, Regina Ramon Hospital General Universitario de Alicante, C/Pintor Baeza s/n, 03010 Alicante, Spain Bevacizumab is a humanized monoclonal antibody that inhibits vascular endothelial growth factor A (VEGF-A). It is approved for metastatic colon cancer, non-small cell lung cancer, renal adenocarcinoma and recently has been FDA-approved in the treatment of recurrent [...]